Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Melanoma
100%
Spatio
100%
Co-sensitization
100%
BRAF Inhibitor (BRAFi)
66%
Numerical Results
33%
Partial Differential Equations
33%
Cell Population
33%
Heterogeneous Conditions
33%
Environmental Heterogeneity
33%
Drug Strategy
33%
Treatment Efficacy
33%
Spatially Homogeneous
33%
Evolutionary
33%
Tumor Cell Subpopulations
33%
Tumor Therapy
33%
Drug Resistance
33%
Rapid Development
33%
Tumor Volume
33%
Tumor Environment
33%
Treatment Results
33%
Tumor Resistance
33%
Resistance Development
33%
Metabolic Model
33%
Drug-resistant Tumor
33%
Population Sequencing
33%
Advanced Melanoma
33%
Overall Survival of Patients
33%
MEK Inhibitor (MEKi)
33%
Gradual Evolution
33%
Long-term Resistance
33%
Novel Targeted Therapy
33%
Murine Melanoma Model
33%
Patient-derived Xenograft
33%
Secondary Waves
33%
Immunology and Microbiology
Sensitization
100%
Cell Population
50%
Xenograft
50%
Tumor Cell
50%
Overall Survival
50%
Drug Resistance
50%
Tumor Volume
50%
Immunotherapy
50%
Medicine and Dentistry
Sensitization
100%
Melanoma
100%
Neoplasm
40%
Cell Population
20%
Xenograft
20%
Tumor Cell
20%
Cancer Therapy
20%
Combination Therapy
20%
Overall Survival
20%
Targeted Therapy
20%
Drug Resistance
20%
Immunotherapy
20%
Tumor Resistance
20%
Biochemistry, Genetics and Molecular Biology
Genetics
100%
Sensitization
100%
Drug Resistance
50%
Overall Survival
50%
Tumor Volume
50%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Neoplasm
80%
Combination Therapy
20%
Overall Survival
20%
Drug Resistance
20%
Immunotherapy
20%
Tumor Resistance
20%